The pharmaceutical contract manufacturing and research services market would grow at a CAGR of 7.74% over the predicted time frame. The market is expected to increase in value from US$ 221.95 Bn in 2022 to US$ 403 Bn in 2030.
The on pharmaceutical contract manufacturing and research services Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/2193
Report Scope of the Pharmaceutical Contract Manufacturing and Research Services Market
| Report Coverage | Details |
| Market Size in 2022 |
USD 221.95 Billion |
| Market Size by 2030 |
USD 403 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 7.74% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Service, End-User, and Geography |
A recent report provides crucial insights along with application based and Forecast information in the Global Pharmaceutical contract manufacturing and research services Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Pharmaceutical contract manufacturing and research services market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Pharmaceutical contract manufacturing and research services market are included as given below:
Pharmaceutical contract manufacturing and research services Market Key Players
- Thermo Fisher Scientific Inc.
- Recipharm AB
- Piramal Pharma Solutions
- Jubilant Pharmova Limited
- Curia Global, Inc.
- Cambrex Corporation
- CordenPharma International
- Samsung Biologics
- FAMAR Health Care Services
- WuXiAppTec
Market Segments
By Service
- Manufacturing
- API/Bulk Drugs
- Advanced Drug Delivery Formulations Packaging
- Packaging
- Finished Dose Formulations
- Solid Formulations
- Liquid Formulations
- Semi-solid Formulations
- Research
- Oncology
- Vaccines
- Inflammation & Immunology
- Cardiology
- Neuroscience
- Others
By End-User
- Big Pharma
- Small Pharma
- Generic Pharma
- Contract Research Organizations
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Report Objectives
- To define, describe, and forecast the global pharmaceutical contract manufacturing and research services market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the pharmaceutical contract manufacturing and research services market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Pharmaceutical Contract Manufacturing and Research Services Market
5.1. COVID-19 Landscape: Pharmaceutical Contract Manufacturing and Research Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Pharmaceutical Contract Manufacturing and Research Services Market, By Service
8.1. Pharmaceutical Contract Manufacturing and Research Services Market, by Service, 2022-2030
8.1.1. Manufacturing
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Research
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Pharmaceutical Contract Manufacturing and Research Services Market, By End-User
9.1. Pharmaceutical Contract Manufacturing and Research Services Market, by End-User, 2022-2030
9.1.1. Big Pharma
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Small Pharma
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Generic Pharma
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Contract Research Organizations
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Pharmaceutical Contract Manufacturing and Research Services Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Service (2017-2030)
10.1.2. Market Revenue and Forecast, by End-User (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Service (2017-2030)
10.1.3.2. Market Revenue and Forecast, by End-User (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Service (2017-2030)
10.1.4.2. Market Revenue and Forecast, by End-User (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Service (2017-2030)
10.2.2. Market Revenue and Forecast, by End-User (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Service (2017-2030)
10.2.3.2. Market Revenue and Forecast, by End-User (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Service (2017-2030)
10.2.4.2. Market Revenue and Forecast, by End-User (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Service (2017-2030)
10.2.5.2. Market Revenue and Forecast, by End-User (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Service (2017-2030)
10.2.6.2. Market Revenue and Forecast, by End-User (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Service (2017-2030)
10.3.2. Market Revenue and Forecast, by End-User (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Service (2017-2030)
10.3.3.2. Market Revenue and Forecast, by End-User (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Service (2017-2030)
10.3.4.2. Market Revenue and Forecast, by End-User (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Service (2017-2030)
10.3.5.2. Market Revenue and Forecast, by End-User (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Service (2017-2030)
10.3.6.2. Market Revenue and Forecast, by End-User (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Service (2017-2030)
10.4.2. Market Revenue and Forecast, by End-User (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Service (2017-2030)
10.4.3.2. Market Revenue and Forecast, by End-User (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Service (2017-2030)
10.4.4.2. Market Revenue and Forecast, by End-User (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Service (2017-2030)
10.4.5.2. Market Revenue and Forecast, by End-User (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Service (2017-2030)
10.4.6.2. Market Revenue and Forecast, by End-User (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Service (2017-2030)
10.5.2. Market Revenue and Forecast, by End-User (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Service (2017-2030)
10.5.3.2. Market Revenue and Forecast, by End-User (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Service (2017-2030)
10.5.4.2. Market Revenue and Forecast, by End-User (2017-2030)
Chapter 11. Company Profiles
11.1. Thermo Fisher Scientific Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Recipharm AB
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Piramal Pharma Solutions
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Jubilant Pharmova Limited
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Curia Global, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Cambrex Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. CordenPharma International
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Samsung Biologics
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. FAMAR Health Care Services
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. WuXiAppTec
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: [email protected]
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
This post first appeared on Healthcare BPO Market Size At Around US$ 755.76 Bn In 2030, please read the originial post: here
